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Tuberculous myositis is extremely rare, even in immunocompromised hosts. We present 
a case of disseminated tuberculous myositis in a girl with secondary acute myelog-
enous leukemia following successful chemotherapy for undifferentiated sarcoma of 
the maxillary sinus. The diagnosis was established by direct visualization of acid-fast 
bacilli in the biopsied nodule and by typical pathologic findings. Three weeks after 
initiation of antituberculosis treatment, the patient experienced both clinical and radi-
ologic improvement.
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Musculoskeletal tuberculosis accounts for 1−3% of all 
cases of tuberculosis. The majority of cases involve 
the thigh, presenting with a cold abscess, a protrud-
ing mass, and pain.1,2 However, disseminated involve-
ment of multiple skeletal muscular groups is rarely 
seen, and its manifestation may mimic septic emboli, 
leading to misdiagnosis. We report a patient with sec-
ondary acute myelogenous leukemia (AML) after in-
duction chemotherapy that developed disseminated 
tuberculous myositis of all four limbs, with a presump-
tive diagnosis of pyomyositis.
2. Case Report
A 10-year and 7-month-old girl was diagnosed with 
stage III undifferentiated sarcoma of the right maxil-
lary sinus at the age of 7 years. She was treated 
with chemotherapy and radiotherapy, and achieved 
complete remission that lasted for 2 years. One year 
after discontinuing chemotherapy, the patient de-
veloped AML. She received induction chemotherapy 
for AML and achieved complete remission 1 month 
after initi ation of chemotherapy.
One week after complete remission, the patient 
visited our clinic because of painful subcutaneous 
nodules over her four limbs and low-grade fever. 
Physical examination showed that the nodules were 
fixed, tender, and woody in consistency, with no ery-
thematous changes in the overlying skin. The nodules 
were about 1 cm2 in size. Hematological examination 
revealed a leukocyte count of 12,600/mm3, with 
79.3% neutrophils and 6% lymphocytes, hemoglobin 
of 8.3 gm/dL and a platelet count of 688 ˜  103/mm3. 
Biochemical studies showed no significant findings, 
except for elevated C-reactive protein of 123.4 mg/L 
(normal range < 5 mg/L).
Diffuse muscle pain accompanied by multiple 
painful subcutaneous nodules led to an initial diag-
nosis of myositis. Empiric antibiotics combined with 
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teicoplanin, ceftazidime and fluconazole were pre-
scribed. However, blood cultures yielded no bacterial 
growth. The subcutaneous nodules spread and the 
pa tient assumed a limping gait over the following 
few days. As the patient’s clinical condition dete-
riorated rapidly, magnetic resonance images (MRI) 
was performed to evaluate the extent of the soft tis-
sue lesions. MRI of both legs showed multiple, small, 
thick-walled cystic nodules in the soft tissue of both 
legs, with enhancement of the walls of the cystic 
nod ules and the surrounding soft tissue, indicative 
of myositis. On T1-weighted images (T1WI), the nod-
ules were of low signal intensity surrounded by bright 
peripheral rings, while on T2-weighted images (T2WI), 
they were of high signal intensity (Figure 1A). 
No evidence of involvement of the adjacent tissue 
or venous thrombosis made Mycobacterium tubercu-
losis, rather than bacteria, the more likely respon-
sible pathogen.
Surgical excision of one of the intramuscular 
nodules was performed and the pathology result 
revealed caseous necrosis with chronic granulo-
matous inflammation, histiocytes, giant cells and 
mono nuclear cells (Figure 2A). Ziehl-Neelson stain-
ing revealed many acid-fast positive bacilli on light 
mi croscopic examination (Figure 2B). The biopsied 
specimen was negative for aerobes, anaerobes, fungi 
and tuberculosis culture. However, as the pathologi-
cal results showed typical feature of M. tuberculosis 
infection, four-drug combined antituberculosis 
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Figure 1 (A) Magnetic resonance imaging of both legs revealed multiple high signal intramuscular nodules surrounded 
by low signal peripheral rim on T2-weighted images. (B) Magnetic resonance imaging of lower legs after 3-week 
antituberculosis treatment revealed regression of the intramuscular nodules on T2-weighted images.
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Figure 2 (A) Caseous necrosis with chronic granulomatous inflammation, histiocytes (dashed arrows), multinucle-
ated giant cells (arrows) and mononuclear cells (hematoxylin and eosin stain, 400˜). (B) Ziehl-Neelson stain revealed 
many acid-fast positive bacilli (arrows) (1000˜).
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chemotherapy was initiated with isoniazid, rifampin, 
pyrazinamide and ethambutol.
Abdominal computed tomography was performed 
to gain a better understanding of the extent of the 
disseminated disease, and neither intrahepatic nor 
splenic microabscesses were noted. In addition, a 
gallium scan revealed multiple focal areas of in-
creased uptake in the soft tissue over arms, fore-
arms, thighs, lower legs and left foot. Overall, the 
images indicated disseminated myositis. Meanwhile, 
the girl underwent examinations to determine the 
entry site of M. tuberculosis, including chest X-ray 
films, tuberculin skin test, acid-fast stain and sputum 
culture for M. tuberculosis, all of which revealed 
negative findings. Epidemiologic surveys of the pa-
tient’s family revealed no evidence of active myco-
bacterial infection.
After 3 weeks of antituberculosis treatment, the 
lesions had almost completely resolved, and the girl 
was able to walk without aid. Follow-up MRI of her 
lower legs revealed marked regression of the intra-
muscular nodules (Figure 1B). Her treatment was 
changed to a triple drug regimen 2 months after the 
initiation of treatment, and this was continued for 
an additional 10 months to ensure adequate treat-
ment of this advanced disease.
3. Discussion
Tuberculosis remains one of the deadliest diseases in 
the world. Around 1−3% of patients have musculoskel-
etal involvement, mostly spondylitis, osteomyelitis or 
arthritis. Tuberculous myositis is extremely rare, 
with an estimated incidence of 0.015−2%. To date, 
nearly 70 cases of tuberculous myositis have been 
reported in the English literature1,2 including cases 
involving single or multiple muscle groups. Multiple 
muscle groups were involved in our case, and dis-
seminated intramuscular abscesses were found in 
each of the involved muscles. The non-specific clini-
cal manifestations of M. tuberculosis myositis mean 
that it is commonly misdiagnosed as malignant or 
other inflammatory diseases.1,2
Most cases of M. tuberculosis myositis are initially 
diagnosed as bacterial pyomyositis. Although it is dif-
ficult to differentiate between M. tuberculosis and 
bacterial pyomyositis in the early stage of disease, 
MRI findings can help to distinguish between them. 
On MRI exam, M. tuberculosis myositis is characteri-
zed by low signal intensity on T1WI and high signal 
intensity on T2WI in a single muscle, with peripheral 
rims showing subtle hyperintensity on T1WI and hy-
pointensity on T2WI. After gadolinium infusion, pe-
ripheral rim enhancement is observed in all cases.3 
Unlike pyogenic myositis, neither cellulitis nor venous 
thrombosis surrounded the involved muscle. Accurate 
diagnosis also depends on the typical histopatho-
logic findings of M. tuberculosis infection, with 
caseous necrosis, granulomas, giant cells, acid-fast 
bacilli, and positive mycobacterial culture. In our 
case, the patient was receiving chemotherapy, and 
the nega tive tuberculin skin test result was pro-
bably due to her altered immune status, and thus 
was of limited use in the diagnosis of mycobacte-
rium infection. Non-tuberculous mycobacteria (NTM), 
Nocardia and Cryptosporidium should also be taken 
into account in the differential diagnosis of organisms 
that are acid-fast stain-positive. Negative mucin 
stain, Gomori methenamine silver stain (GMS) and 
periodic acid-Schiff stain make Cryptosporidium less 
likely, while the larger size and the round shape 
easily differentiates Nocardia. Owing to the inade-
quate size of the biopsy specimen, M. tuberculosis 
polymerase chain reaction study was not possible. 
However, the scarcity of the organisms scattered 
in the granuloma, rather than large numbers of acid-
fast bacilli, was a characteristic pathologic finding 
allowing M. tubercu losis to be differentiated from 
NTM in our case.4 Taken together, the typical patho-
logic features, the geographic consideration, and the 
excellent response to antituberculosis medications 
resulted in a diagnosis of M. tuberculosis infection.
Tuberculous myositis occurs more frequently in 
patients with acquired immunodeficiency syndrome. 
In 1997, del Giglio et al reported two cases of tuber-
culous myositis in patients with acute leukemia. 
Both cases developed musculoskeletal pain after 
induction chemotherapy, one involving the left leg 
and the other the left gluteal muscle and left 
thigh.5 Hematogenous dissemination plays an im-
portant role in M. tuberculosis myositis, especially 
in immunocompromised patients. The involved le-
sion is usually limited to one muscle, but the involve-
ment of several muscles has been reported.6 In our 
case, myositis involving multiple anatomical sites 
implied that the route of mycobacterial infection 
may have been hematogenous, despite failure to 
identify the port of entry. We believe that a previous 
tuberculous infection from an unrecognized focus 
was reactivated following changes in immune status 
caused by induction chemotherapy.
The presentations of tuberculous myositis may 
mimic those of autoimmune polymyositis, dermato-
myositis and malignant diseases.2,5,7 Myalgia and 
limp ing gait frequently develop in patients with acute 
leukemia after induction chemotherapy. They are 
usually attributed to drug effects, such as peripheral 
neuropathy caused by vincristine or dermatomyositis 
resulting from all-trans retinoic acid treatment, which 
make a correct diagnosis more difficult.7−9 How-
ever, the symptoms caused by drugs are self lim-
ited. In con trast to the MRI findings characteristic of 
M. tuberculosis myositis, malignant lesions tend to 
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have shaggy or irregular shapes, and show invasion 
into the adjacent tissue. The radiographic character-
istics are helpful in differentiating myositis from 
drug-induced myositis or malignant disease.
There is currently no consensus on the optimal 
treatment regimen for disseminated tuberculous 
myo sitis. In most cases, timely diagnosis, effective 
drain age and appropriate antituberculosis therapy 
make the prognosis for functional recovery good.1,2,6,10 
Identification of sequelae is important if bony inva-
sion coexists with the soft tissue lesions, because 
bony invasion carries a poorer prognosis.2 An ex-
tended treatment duration is indicated when bony 
invasion is identified. Moreover, most authors agree 
that medical treatment for 10 months is adequate 
for tuberculous myositis alone, but at least 12 months 
is required in patients with bony invasion.1−3,6 In our 
case, because the girl was simultaneously being 
treated with chemotherapy for leukemia, 10 months 
of triple drug antituberculous treatment was pre-
scribed following 2 months of a four-drug combined 
regimen to ensure adequate treatment and preven-
tion of M. tuberculosis reactivation, despite a lack of 
evidence of bony invasion.
In conclusion, we have presented an AML patient 
with disseminated tuberculous myositis who was 
treated successfully with antituberculosis chemother-
apy. Disseminated myositis with rapid progression or 
clinical deterioration in immunocompromised pa-
tients should increase the suspicion of tuberculosis 
infection in endemic areas, so facilitating early 
diagnosis and reducing the mortality and morbidity.
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